ACET

Adicet Bio, Inc.

SEC CIK 1720580
$8.05 +8.3% · 90 days
90-day buys
$0
0 open-market
90-day sells
$674.8K
4 open-market
Net insider flow
−$674.8K
Net selling
Filings shown
34
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at ACET have sold a net $674.8K of stock (0 open-market buys vs 4 sells).

Largest recent trade: Orbimed Advisors Llc, ACET's 10% owner, spent $4.42M of their own money on 1.84M shares at $2, growing their stake 32%.

Most active filer: Orbimed Advisors Llc, with 13 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for ACET, newest first
View on SEC EDGAR ↗
ACET
Sell ORBIMED ADVISORS LLC · 10% Owner · Open-market sale · filed Apr 9, 2026 ΔOwn −100%

Orbimed Advisors Llc sold $204.6K of ACET, trimming their stake 100%.

−$204.6K
32,523 sh @ $6
ACET
Sell ORBIMED ADVISORS LLC · 10% Owner · Open-market sale · filed Apr 9, 2026 ΔOwn −100%

Orbimed Advisors Llc sold $263.5K of ACET, trimming their stake 100%.

−$263.5K
40,416 sh @ $7
ACET
Sell ORBIMED ADVISORS LLC · 10% Owner · Open-market sale · filed Apr 9, 2026 ΔOwn −46%

Orbimed Advisors Llc sold $191.5K of ACET, trimming their stake 46%.

−$191.5K
29,319 sh @ $7
ACET
Sell ORBIMED ADVISORS LLC · 10% Owner · Open-market sale · filed Apr 9, 2026 ΔOwn −6.9%

Orbimed Advisors Llc sold $15.3K of ACET, trimming their stake 7%.

−$15.3K
2,400 sh @ $6
Advertisement
ACET
Buy RA CAPITAL MANAGEMENT, L.P.★ 17% · 10% Owner · Open-market purchase · filed Apr 13, 2026 ΔOwn +6.7%

Ra Capital Management, L.p., ACET's 10% owner, spent $543.4K of their own money on 74,751 shares at $7, growing their stake 7%. Their tracked buys have a 17% win rate.

+$543.4K
74,751 sh @ $7
ACET
Buy RA CAPITAL MANAGEMENT, L.P.★ 17% · 10% Owner · Open-market purchase · filed Apr 13, 2026 ΔOwn +7.2%

Ra Capital Management, L.p., ACET's 10% owner, spent $535.5K of their own money on 74,268 shares at $7, growing their stake 7%. Their tracked buys have a 17% win rate.

+$535.5K
74,268 sh @ $7
ACET
Buy RA CAPITAL MANAGEMENT, L.P.★ 17% · 10% Owner · Open-market purchase · filed Apr 13, 2026 ΔOwn +7.8%

Ra Capital Management, L.p., ACET's 10% owner, spent $525K of their own money on 74,577 shares at $7, growing their stake 8%. Their tracked buys have a 17% win rate.

+$525K
74,577 sh @ $7
ACET
Tax withholding Aftab Blake · Chief Scientific Officer · Tax withholding · filed Jan 27, 2026 ΔOwn −15%
−$4.5K
535 sh @ $8
ACET
Tax withholding Healey Don · Chief Technology Officer · Tax withholding · filed Jan 27, 2026 ΔOwn −13%
−$4.5K
535 sh @ $8
ACET
Tax withholding Schor Chen · Director, President & CEO · Tax withholding · filed Jan 27, 2026 ΔOwn −20%
−$14.8K
1,755 sh @ $8
ACET
Buy ORBIMED ADVISORS LLC · 10% Owner · Open-market purchase · filed Oct 10, 2025 ΔOwn +20%

Orbimed Advisors Llc, ACET's 10% owner, spent $1.5M of their own money on 1.5M shares at $1, growing their stake 20%.

+$1.5M
1.5M sh @ $1
ACET
Buy ORBIMED ADVISORS LLC · 10% Owner · Open-market purchase · filed Oct 10, 2025 ΔOwn +353%

Orbimed Advisors Llc, ACET's 10% owner, spent $3.5M of their own money on 3.5M shares at $1, growing their stake 353%.

+$3.5M
3.5M sh @ $1
ACET
Tax withholding Schor Chen · Director, President & CEO · Tax withholding · filed Jan 28, 2025 ΔOwn −17%
−$25.9K
28,101 sh @ $1
ACET
Buy ORBIMED ADVISORS LLC · Director, 10% Owner · Open-market purchase · filed Jan 26, 2024 ΔOwn +32%

Orbimed Advisors Llc, ACET's 10% owner, spent $4.42M of their own money on 1.84M shares at $2, growing their stake 32%.

+$4.42M
1.84M sh @ $2
ACET
Buy ORBIMED ADVISORS LLC · Director, 10% Owner · Open-market purchase · filed Jan 26, 2024 ΔOwn +32%

Orbimed Advisors Llc, ACET's 10% owner, spent $581.3K of their own money on 242,200 shares at $2, growing their stake 32%.

+$581.3K
242,200 sh @ $2
ACET
Buy ORBIMED ADVISORS LLC · Director, 10% Owner · Open-market purchase · filed Jan 26, 2024 ΔOwn +486%

Orbimed Advisors Llc, ACET's 10% owner, spent $2.5M of their own money on 1.04M shares at $2, growing their stake 486%.

+$2.5M
1.04M sh @ $2
ACET
Buy GORDON CARL L · Director, 10% Owner · Open-market purchase · filed Jan 26, 2024 ΔOwn +32%

Gordon Carl L, ACET's 10% owner, spent $4.42M of their own money on 1.84M shares at $2, growing their stake 32%.

+$4.42M
1.84M sh @ $2
ACET
Buy GORDON CARL L · Director, 10% Owner · Open-market purchase · filed Jan 26, 2024 ΔOwn +32%

Gordon Carl L, ACET's 10% owner, spent $581.3K of their own money on 242,200 shares at $2, growing their stake 32%.

+$581.3K
242,200 sh @ $2
ACET
Buy GORDON CARL L · Director, 10% Owner · Open-market purchase · filed Jan 26, 2024 ΔOwn +486%

Gordon Carl L, ACET's 10% owner, spent $2.5M of their own money on 1.04M shares at $2, growing their stake 486%.

+$2.5M
1.04M sh @ $2
ACET
Buy GORDON CARL L · Director, 10% Owner · Open-market purchase · filed Jun 29, 2023 ΔOwn +14%

Gordon Carl L, ACET's 10% owner, spent $261.3K of their own money on 125,000 shares at $2, growing their stake 14%.

+$261.3K
125,000 sh @ $2
ACET
Buy GORDON CARL L · Director, 10% Owner · Open-market purchase · filed Jun 29, 2023 ΔOwn +63%

Gordon Carl L, ACET's 10% owner, spent $522.5K of their own money on 250,000 shares at $2, growing their stake 63%.

+$522.5K
250,000 sh @ $2
ACET
Buy GORDON CARL L · Director, 10% Owner · Open-market purchase · filed Jun 29, 2023 ΔOwn +8.4%

Gordon Carl L, ACET's 10% owner, spent $923.8K of their own money on 442,000 shares at $2, growing their stake 8%.

+$923.8K
442,000 sh @ $2
ACET
Buy GORDON CARL L · Director, 10% Owner · Open-market purchase · filed Jun 29, 2023 ΔOwn +8.4%

Gordon Carl L, ACET's 10% owner, spent $121.2K of their own money on 58,000 shares at $2, growing their stake 8%.

+$121.2K
58,000 sh @ $2
Advertisement

About ACET insider activity

This page tracks every recent Form 4 filed for Adicet Bio, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is ACET insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Adicet Bio, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.